Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.92%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.16%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.78%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.43%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
23.58%
Tags
-
Rhea-AI Summary
ImmunoPrecise Antibodies filed a Form 6-K (foreign issuer report) on June 28, 2025, indicating the submission of a press release dated June 24, 2025. The filing was signed by Jennifer Bath, who serves as President and Chief Executive Officer.
The company confirms it will file annual reports under Form 20-F rather than Form 40-F. The principal executive office is located in Austin, Texas.
Note: While this is a Form 6-K filing, the actual content and details of the press release (Exhibit 99.1) are not included in this portion of the filing. The Form 6-K serves primarily as a cover document for the attached press release, which would contain the material information being reported to shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.09%
Tags
FAQ
How many MindWalk Holdings (IPA) SEC filings are available on StockTitan?
StockTitan tracks 26 SEC filings for MindWalk Holdings (IPA), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for MindWalk Holdings (IPA)?
The most recent SEC filing for MindWalk Holdings (IPA) was filed on July 24, 2025.